Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-89
SponsorLoma Linda University
About this trial
Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups.
Eligibility criteria
Qualifiers
Patients undergoing lead implantation for sacral neuromodulation that have overactive bladder as defined by urinary urgency, frequency, nocturia with or without urgency incontinence.
Disqualifiers
neurogenic bladder, BMI >40, or peripheral neuropathy.
Trial design
Treatments tested in this trial
- Reduced radiation fluoroscopy
- Conventional fluoroscopy
Treatment groups
44 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov